Evidence map›Paper›PMID 25739698›Full record

ArticlePlant physiology2015

The Xanthomonas campestris type III effector XopJ proteolytically degrades proteasome subunit RPT6.

Suayib Üstün, Frederik Börnke

Open access · hybridAbstract read
In one paragraph

Article in Plant physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
11.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A Pipeline to Monitor Proteasome Homeostasis in Plants.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Secrete or perish: The role of secretion systems inComputational and structural biotechnology journal · 2021
    Review
  12. Article
  13. Natural Variation in Virulence ofThe plant pathology journal · 2020
    Article
  14. The Role of Proteases in the Virulence of Plant Pathogenic Bacteria.International journal of molecular sciences · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Suayib ÜstünPlant Metabolism Group, Leibniz Institute of Vegetable and Ornamental Crops, 14979 Grossbeeren, Germany (S.Ü., F.B.);Friedrich-Alexander-University Erlangen-Nuremberg, Department of Biology, Division of Biochemistry, 91058 Erlangen, Germany (S.Ü., F.B.); andInstitut of Biochemistry and Biology, University of Potsdam, 14476 Potsdam, Germany (F.B.) uestuen@igzev.de boernke@igzev.de.ORCID http://orcid.org/0000-0002-8049-296X
Frederik BörnkePlant Metabolism Group, Leibniz Institute of Vegetable and Ornamental Crops, 14979 Grossbeeren, Germany (S.Ü., F.B.);Friedrich-Alexander-University Erlangen-Nuremberg, Department of Biology, Division of Biochemistry, 91058 Erlangen, Germany (S.Ü., F.B.); andInstitut of Biochemistry and Biology, University of Potsdam, 14476 Potsdam, Germany (F.B.) uestuen@igzev.de boernke@igzev.de.ORCID http://orcid.org/0000-0003-3558-0482
Leibniz Institute of Vegetable and Ornamental Crops · DEUniversity of Potsdam · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many animal and plant pathogenic bacteria inject type III effector (T3E) proteins into their eukaryotic host cells to suppress immunity. The Yersinia outer protein J (YopJ) family of T3Es is a widely distributed family of effector proteins found in both animal and plant pathogens, and its members are highly diversified in virulence functions. Some members have been shown to possess acetyltransferase activity; however, whether this is a general feature of YopJ family T3Es is currently unknown. The T3E Xanthomonas outer protein J (XopJ), a YopJ family effector from the plant pathogen Xanthomonas campestris pv vesicatoria, interacts with the proteasomal subunit Regulatory Particle AAA-ATPase6 (RPT6) in planta to suppress proteasome activity, resulting in the inhibition of salicylic acid-related immune responses. Here, we show that XopJ has protease activity to specifically degrade RPT6, leading to reduced proteasome activity in the cytoplasm as well as in the nucleus. Proteolytic degradation of RPT6 was dependent on the localization of XopJ to the plasma membrane as well as on its catalytic triad. Mutation of the Walker B motif of RPT6 prevented XopJ-mediated degradation of the protein but not XopJ interaction. This indicates that the interaction of RPT6 with XopJ is dependent on the ATP-binding activity of RPT6, but proteolytic cleavage additionally requires its ATPase activity. Inhibition of the proteasome impairs the proteasomal turnover of Nonexpressor of Pathogenesis-Related1 (NPR1), the master regulator of salicylic acid responses, leading to the accumulation of ubiquitinated NPR1, which likely interferes with the full induction of NPR1 target genes. Our results show that YopJ family T3Es are not only highly diversified in virulence function but also appear to possess different biochemical activities.

Indexed as

Bacterial Secretion SystemsProteolysisAdaptor Proteins, Signal TransducingAmino Acid MotifsATPases Associated with Diverse Cellular ActivitiesBacterial ProteinsGreen Fluorescent ProteinsHeLa CellsHumansLIM Domain ProteinsProteasome Endopeptidase ComplexProtein BindingProtein StabilityProtein SubunitsTranscription FactorsXanthomonas campestrisAdaptor Proteins, Signal TransducingATPases Associated with Diverse Cellular ActivitiesBacterial ProteinsBacterial Secretion SystemsGreen Fluorescent ProteinsLIM Domain ProteinsProteasome Endopeptidase ComplexProtein SubunitsPSMC5 protein, humanTranscription Factors

Identifiers

PMID25739698
PMCPMC4424027
OpenAlexW2064901504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.